4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-023372
PRESIDENT AND CEO sold 15,625 shares at an average $37.50 ($585,934)
- PRESIDENT AND CEO acquired 15,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-09-11 | Option exercise 10b5-1 | +9,274 | $2.90 | $26,865 | 317,246 | D: show line 1 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-09-11 | Sale 10b5-1 | −9,274 | $37.31 | $346,023 | 307,972 | D: show line 2 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-09-11 | Option exercise 10b5-1 | +6,351 | $2.90 | $18,398 | 314,323 | D: show line 3 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-09-11 | Sale 10b5-1 | −6,351 | $37.78 | $239,911 | 307,972 | D: show line 4 in the form |
| Open-market sales · 15,625 sh · avg $37.50 · $585,934 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-09-11 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 827,337 | D: show line 5 in the form |
Loading xslF345X05/form4-09132024_080943.xml…